Pharma Tech

Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status

Aug 18, 2026, 9:09 AM

Read Full Article → Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status

Translate article text

Choose a language and wait for the translated text.

Faeth Therapeutics has received fast track designation from the FDA for the PIKTOR with paclitaxel combination to treat advanced or recurrent endometrial cancer.